Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression ; volume:9 ; number:1 ; day:24 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023
Cell death discovery ; 9, Heft 1 (24.10.2023), 1-12, 12.2023
- Urheber
-
Hong, Zhe
Xu, Chengdang
Zheng, Shengfeng
Wang, Xinan
Tao, Yiran
Tan, Yao
Lin, Guowen
Wu, Denglong
Ye, Dingwei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-023-01682-w
- URN
-
urn:nbn:de:101:1-2024020512060514761286
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hong, Zhe
- Xu, Chengdang
- Zheng, Shengfeng
- Wang, Xinan
- Tao, Yiran
- Tan, Yao
- Lin, Guowen
- Wu, Denglong
- Ye, Dingwei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oct4 cooperates with c-Myc to improve mesenchymal-to-endothelial transition and myocardial repair of cardiac-resident mesenchymal stem cells
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
Humanized c-Myc Mouse
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
c-myc function in neoplasia
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
C-myc in der humanen Muskelzellenentwicklung
C-myc in B-cell neoplasia
Targeting c-MYC with T-Cells
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer
Oct4 cooperates with c-Myc to improve mesenchymal-to-endothelial transition and myocardial repair of cardiac-resident mesenchymal stem cells
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
Humanized c-Myc Mouse
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
c-myc function in neoplasia
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
C-myc in der humanen Muskelzellenentwicklung
C-myc in B-cell neoplasia
Targeting c-MYC with T-Cells
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer
Oct4 cooperates with c-Myc to improve mesenchymal-to-endothelial transition and myocardial repair of cardiac-resident mesenchymal stem cells
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
Humanized c-Myc Mouse
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
c-myc function in neoplasia
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
C-myc in der humanen Muskelzellenentwicklung
C-myc in B-cell neoplasia
Targeting c-MYC with T-Cells